已收盘 12-19 16:00:00 美东时间
-0.180
-0.52%
今日重点评级关注:摩根士丹利:维持Kyverna Therapeutics"超配"评级,目标价从20美元升至25美元;Maxim Group:维持Capricor Therapeutics"买入"评级,目标价从25美元升至50美元
12-05 08:35
Truist Securities analyst Michael Swartz maintains United Parks & Resorts (NYSE:PRKS) with a Buy and lowers the price target from $61 to $47.
12-05 00:27
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从12美元升至15美元;Canaccord Genuity:维持Viking Therapeutics"买入"评级,目标价从106美元升至107美元
11-13 09:58
今日重点评级关注:Piper Sandler:维持MeiraGTx Hldgs"超配"评级,目标价从28美元升至30美元;RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从26美元升至32美元
11-12 11:43
United Parks & Resorts shares are trading lower after the company reported ...
11-06 20:55
United Parks & Resorts (NYSE:PRKS) reported quarterly earnings of $1.61 per share which missed the analyst consensus estimate of $2.27 by 29.17 percent. This is a 22.6 percent decrease over earnings of $2.08 per share
11-06 19:31
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12
An update from United Parks & Resorts ( ($PRKS) ) is now available. On Sept...
09-05 21:28
https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20250902-1479717/1479717_4skx6fl.pdf
09-03 05:19